))
Mythbusting LCS in Pulmonology: Patient Expectations Regarding Tobacco Treatment (Part 2)
Manage episode 336657130 series 3378142
Innehåll tillhandahållet av American College of Radiology and National Lung Cancer Roundtable, American College of Radiology, and National Lung Cancer Roundtable. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av American College of Radiology and National Lung Cancer Roundtable, American College of Radiology, and National Lung Cancer Roundtable eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020.
Dr. Debra Dyer, MD, continues her conversation with Dr. Gerard Silvestri, MD, about what a patient can expect regarding tobacco treatment in the context of lung cancer screening in part two of this five-part conversation.
As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.”
Dr. Gerard Silvestri is a lung cancer pulmonologist at the Medical University of South Carolina. He has served on the Data and Safety Monitoring Board of the national Prostate, Lung, Colorectal and Ovarian screening trial, representing the lung arm of the trial. Dr. Silvestri participates as a Steering Committee member and Task Group Chair on the American Cancer Society’s National Lung Cancer Screening Roundtable Steering Committee.
Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.
40 episoder
Dela
